Evidence map›Paper›PMID 41306779›Full record

ArticleFrontiers in pharmacology2025

Optimization of response surface methodology for the extraction of isoliquiritigenin from

Jingwei Hao, Qiuxuan Li, Nan Dong, Yi Zhou, Yifan Sun, Yingying Pei, Xiangkun Zhou, Lei Yang

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingwei HaoSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Qiuxuan LiSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Nan DongSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Yi ZhouSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Yifan SunSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Yingying PeiSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Xiangkun ZhouSchool of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
Lei YangDepartment of Pediatrics, The Second Affiliated Hospital of Mudanjiang Medical University, Mudanjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research focused on optimizing the extraction of isoliquiritigenin (ISL) from licorice via a solid-state fermentation process involving

Indexed as

antitumorintestinal floraisoliquiritigeninlicoricesolid-state fermentation of Aspergillus niger

Identifiers

PMID41306779
PMCPMC12644103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.